课题基金 / 基金详情

DIABETES CONTROL AND COMPLICATIONS TRIAL (DCCT)

DIABETES CONTROL AND COMPLICATIONS TRIAL (DCCT)
糖尿病控制和并发症试验 (DCCT)
批准号:
3550771
负责人:
ORVILLE G KOLTERMAN
金额:
$46.08万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-07-23 至 1993-06-30

项目摘要

项目成果

ORVILLE G KOLTERMAN的其他基金

相似基金

相关文献

中文摘要
翻译
此应用程序旨在为 糖尿病控制和并发症试验(DCCT) 加州大学圣地亚哥分校(UCSD)。这场审判是一个 由国家关节炎、糖尿病、 和国家消化与肾脏病分会 卫生研究院旨在提供一个明确的答案 关于血糖控制是否出色的问题 预防和/或缓解I型晚期并发症 糖尿病。如果选中,则DCCT的UCSD中心将为 预计将招募、筛选和录入30名合适的科目 为期两年的研究,然后提供指定的 后续护理,直到生物统计学家宣布 在回答以下问题方面已经取得了统计上的力量 问题。因为预计至少7年将 为了实现这一目标,加州大学圣地亚哥分校还需要 承担多个被录取对象的后续护理 在其他地方,谁搬迁到圣地亚哥集水区在 学习的过程。这项研究是在一项 在最近的一次可行性研究中的标准化协议 完成。
英文摘要
This application is designed to establish a center for the Diabetes Control and Complications Trial (DCCT) at the University of California, San Diego (UCSD). This trial is a multi-center trial funded by the National Arthritis, Diabetes, and Digestive and Kidney Diseases branch of the National Institutes of Health designed to provide a definitive answer to the question as to whether or not excellent glycemic control prevents and/or ameloriates the late complications of Type I diabetes. If selected, the UCSD Center of the DCCT will be expected to recruit, screen and enter 30 suitable subjects into the study over a 2-year period and then provide the designated follow-up care until the biostatistician announces that statistical power has been achieved in terms of answering the question. Since it is anticipated that at least 7 years will be required to achieve this goal, the UCSD will also need to assume the follow-up care of a number of subjects enrolled elsewhere who relocate to the San Diego catchment during the course of the study. The study is being conducted under a standardized protocol during a feasibility study recently completed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EPIDEMIOLOGY OF DIABETES INTERVENTION AND COMPLICATIONS
EPIDEMIOLOGY OF DIABETES INTERVENTION AND COMPLICATIONS
EPIDEMIOLOGY OF DIABETES INTERVENTION AND COMPLICATIONS
EPIDEMIOLOGY OF DIABETES INTERVENTION AND COMPLICATIONS
海外基金